IMPACT OF SMOKING HISTORY ON THE REAL-WORLD EFFECTIVENESS OF IMMUNE CHECKPOINT INHIBITORS IN PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER: A NATIONWIDE POPULATION-BASED STUDY

被引：0
|
作者：
Lee, J. [1 ]
Kim, Y. [2 ,3 ]
Suh, H. S. [4 ]
机构：
[1] Kyung Hee Univ, Inst Regulatory Innovat Sci, Grad Sch, Dept Regulatory Sci, Seoul, South Korea
[2] Kyung Hee Univ, Inst Regulatory Innovat Sci IRIS, Coll Pharm, Seoul, South Korea
[3] Univ Texas Austin, Coll Pharm, Hlth Outcomes Div, Austin, TX USA
[4] Kyung Hee Univ, Inst Regulatory Innovat Sci, Coll Pharm, Dept Regulatory Sci,Grad Sch, Seoul, South Korea
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The real-world treatment characteristic and efficacy of immune checkpoint inhibitors in non-small cell lung cancer: Data from a retrospective cohort study
    Zhang, Chenyang
    Shao, Jun
    Tang, Xiaolong
    Wu, Jiayang
    Li, Peiyi
    Li, Weimin
    Wang, Chengdi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 134
  • [32] Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study
    Jiang, Haohua
    Li, Yujing
    Wang, Yanan
    Zou, Benkun
    Chen, Ya
    Zhang, Yanwei
    Husain, Hatim
    Forest, Fabien
    Qian, Fangfei
    Zhang, Lele
    Zhou, Chao
    Liu, Hongyu
    Wang, Danni
    Zhang, Wei
    Lu, Jun
    Han, Baohui
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (07)
  • [33] Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort study
    Hektoen, Helga H.
    Tsuruda, Kaitlyn M.
    Fjellbirkeland, Lars
    Nilssen, Yngvar
    Brustugun, Odd Terje
    Andreassen, Bettina K.
    BRITISH JOURNAL OF CANCER, 2025, 132 (01) : 93 - 102
  • [34] Impact of Mutation Class and Smoking Status in BRAFMutant Non-Small Cell Lung Cancer (NSCLC) Treated with Immune Checkpoint Inhibitors (ICI)
    Marin-Acevedo, J. A.
    Bandikatla, S. V.
    Thapa, R.
    Puri, S.
    Chen, D. -T.
    Hicks, K.
    Gray, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S259 - S260
  • [35] Impact of Antibiotics During Immune Checkpoint Inhibitor (ICI) Therapy for Non-Small Cell Lung Cancer: A Real-World Analysis
    Klink, A.
    Falkenstein, A.
    Chopra, D.
    Gajra, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S298 - S298
  • [36] Prediction of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint inhibitors based on clinical and hematological markers: Real-world evidence
    Xu, Huiru
    Feng, Huijing
    Zhang, Weihong
    Wei, Feng
    Zhou, Li
    Liu, Liang
    Zhao, Yu
    Lv, Yingge
    Shi, Xiuhuan
    Zhang, Junping
    Ren, Xiubao
    EXPERIMENTAL CELL RESEARCH, 2022, 416 (01)
  • [37] Efficacy and Safety of Immune Checkpoint Inhibitors in a Danish Real Life Non-Small Cell Lung Cancer Population
    Bjornhart, B.
    Hansen, K.
    Jorgensen, T.
    Herrstedt, J.
    Schytte, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S979 - S979
  • [38] Prognostic impact of immune checkpoint inhibition in patients with metastatic non-small cell lung cancer (NSCLC): Real-world study in central Switzerland
    Allmann, V.
    Gautschi, O.
    Lehnick, D.
    Dyntar, D.
    Schwegler, C.
    Dressler, M.
    Godau, J.
    Niederberger, P.
    Zeidler, K.
    Diebold, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S53 - S53
  • [39] Immune-Checkpoint Inhibitors-Related Colitis in Advanced Non-small Cell Lung Cancer Patients: A Real-World Analysis
    Lorenzi, M.
    Massa, D.
    Angerilli, V.
    Barberio, B.
    De Ruvo, M.
    Pretelli, G.
    Benetti, B.
    Mulargiu, C.
    Resi, M. V.
    Ferro, A.
    Dal Maso, A.
    Frega, S.
    Pasello, G.
    Guarneri, V.
    Savarino, E. V.
    Fassan, M.
    Bonanno, L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S121 - S122
  • [40] Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer
    Tang, Monica
    Lee, Chee K.
    Lewis, Craig R.
    Boyer, Michael
    Brown, Bernadette
    Schaffer, Andrea
    Pearson, Sallie-Anne
    Simes, Robert J.
    LUNG CANCER, 2022, 166 : 40 - 48
12345